mash and glp 1 Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual triple agonists Exploring the Potential of GLP-1
Description
J., Poulsen, S
Since then, it has been established that the dual centre model regulates feeding [53], that the proposed lesioning of the VMH increases appetite, while stimulating the VMH decreases it
Our model has been deliberately isolated from the influence of the metabolic comorbidities that currently frame the use of this drug, with the goal of revealing any direct effects GLP-1 agonists may exert on cardiac tissue
Check the Drug Administration and Food tool in #CPS under the Tools section today
I love the people that I work with
